News

Find News

Filter articles

Applied Filters

Showing 761 to 770 of 919 results

Teva records another victory in US Supreme Court Copaxone ruling

US20-01-2015Legal developments

The US Supreme Court has vacated an appeals court judgment that invalidated a patent covering Teva’s blockbuster drug Copaxone (glatiramer acetate).

Shionogi sues Aurobindo to halt Doribax generic

US19-01-2015Legal developments

Japanese pharmaceutical company Shionogi has sued Aurobindo Pharma in an attempt to stop the Indian generic drug maker from marketing a version of its antibiotic drug Doribax (doripenem) in the US.

Teva and Mylan get green light to launch Novartis generics

US08-01-2015

Pharmaceutical companies Teva and Mylan have each been granted permission to market a generic version of Novartis’s blood pressure treatment Diovan (valsartan) in the US.

Drug makers on brink of $65bn patent cliff, says report

US12-12-2014

Pharmaceutical companies will suffer an estimated $65 billion drop in sales over the next five years due to the expiry of patents protecting several leading drugs, according to a UK research and consulting firm.

Acne drug at centre of ‘first’ IPR ruling of its kind

US11-12-2014

Pharmaceutical company Supernus and its subsidiary Galderma have had their Oracea (doxycycline) acne treatment drug protected from a generic challenge, in a decision dubbed the “first of its kind”.

Merck insists on buyout despite generic blow

US10-12-2014

Pharmaceutical company Merck has said it will press on with an $8.4 billion buyout of Cubist Pharmaceuticals despite a court ruling that could pave the way for a generic version of a lucrative Cubist drug.

AstraZeneca and Ranbaxy win ‘pay-for-delay’ case

India, US08-12-2014Legal developments

A US court has spared drug companies AstraZeneca and Ranbaxy Laboratories a potentially hefty fine after ruling that a ‘pay-for-delay’ deal between them did not violate antitrust grounds.

Ranbaxy sues FDA over drugs revoke

India, US19-11-2014

Indian drug maker Ranbaxy Laboratories has sued the US Food and Drug Administration and claimed it wrongfully revoked a previous approval for two new drugs.

Canadian Supreme Court case breaks down

Canada04-11-2014

A case that was expected to act as a benchmark for future patent cases in Canada has been settled a day before the country’s Supreme Court was due to hear arguments.

Canadian Supreme Court to hear high-profile patent dispute

Canada03-11-2014Legal developments

Canada’s highest court is set to hear a hotly anticipated dispute pitting generic company Apotex against drug companies Sanofi and Bristol-Myers Squibb (BMS).

Showing 761 to 770 of 919 results

LSIPR